Pfizer’s U.S. Losses Questioned as Overseas Profit Soars

Pfizer Inc., the world’s biggest drugmaker, was asked by U.S. regulators how it recorded high profit overseas and losses at home when 40 percent of its sales were inside the U.S.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.